NOVARTIS INDIA
Back to Cashflow Statement
|
NOVARTIS INDIA Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-64 Cr | ₹-121 Cr | ₹-30 Cr | ₹-36 Cr | ₹-37 Cr |
What is the latest Cash Flow from Financing Activities ratio of NOVARTIS INDIA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-64 Cr |
| Mar2024 | ₹-121 Cr |
| Mar2023 | ₹-30 Cr |
| Mar2022 | ₹-36 Cr |
| Mar2021 | ₹-37 Cr |
How is Cash Flow from Financing Activities of NOVARTIS INDIA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-64 Cr | Negative | |
| Mar2024 | ₹-121 Cr | Negative | |
| Mar2023 | ₹-30 Cr | Negative | |
| Mar2022 | ₹-36 Cr | Negative | |
| Mar2021 | ₹-37 Cr | - | |
Compare Cash Flow from Financing Activities of peers of NOVARTIS INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NOVARTIS INDIA | ₹2,318.7 Cr | 2% | 13.9% | 17.3% | Stock Analytics | |
| ADANI ENTERPRISES | ₹258,491.0 Cr | -5.8% | -10.6% | -0.7% | Stock Analytics | |
| REDINGTON | ₹18,215.3 Cr | -11.3% | -12.8% | 6.1% | Stock Analytics | |
| HONASA CONSUMER | ₹9,338.1 Cr | -2% | 2.1% | 38.5% | Stock Analytics | |
| MMTC | ₹8,197.5 Cr | -6.8% | -13.6% | 16.9% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹7,177.9 Cr | -5.3% | -24.2% | 27% | Stock Analytics | |
NOVARTIS INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NOVARTIS INDIA | 2% |
13.9% |
17.3% |
| SENSEX | -4.6% |
-7.5% |
6% |
You may also like the below Video Courses